Cradle is a Dutch-Swiss biotech company founded in 2021 that uses generative AI to accelerate protein design and optimization. Its intuitive software platform enables scientists to create and refine proteins with improved properties—such as stability, binding affinity, and expression—while reducing the need for costly and time-consuming lab experiments. Trusted by major partners like Novo Nordisk, Johnson & Johnson, and IFF, Cradle supports a wide range of applications from drug discovery to sustainable materials. By combining cutting-edge machine learning with wet lab validation, Cradle is transforming how proteins are engineered across industries.